Unaudited Interim Consolidated Statement of Operations - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Net sales	$ 1,798	$ 1,460
Cost of sales	(1,313)	(1,112)
Gross profit	485	348
Selling, general and administrative expenses	(137)	(125)
Amortization of intangible assets	(6)	(5)
Research and development expenses	(20)	(17)
Other (charges) gains, net	6	(6)
Foreign exchange gain (loss), net	3	(1)
Gain (loss) on disposition of businesses and assets, net	(5)	0
Operating profit (loss)	326	194
Equity in net earnings (loss) of affiliates	29	57
Non-operating pension and other postretirement employee benefit (expense) income	38	28
Interest expense	(25)	(28)
Interest income	1	2
Dividend income - equity investments	42	37
Other income (expense), net	(2)	2
Earnings (loss) from continuing operations before tax	409	292
Income tax (provision) benefit	(85)	(65)
Earnings (loss) from continuing operations	324	227
Earnings (loss) from operation of discontinued operations	(1)	(7)
Income tax (provision) benefit from discontinued operations	0	0
Earnings (loss) from discontinued operations	(1)	(7)
Net earnings (loss)	323	220
Net (earnings) loss attributable to noncontrolling interests	(1)	(2)
Net earnings (loss) attributable to Celanese Corporation	322	218
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations	323	225
Earnings (loss) from discontinued operations	(1)	(7)
Net earnings (loss)	$ 322	$ 218
Earnings (loss) per common share - basic
Continuing operations	$ 2.85	$ 1.89
Discontinued operations	(0.01)	(0.06)
Net earnings (loss) - basic	2.84	1.83
Earnings (loss) per common share - diluted
Continuing operations	2.83	1.88
Discontinued operations	(0.01)	(0.06)
Net earnings (loss) - diluted	$ 2.82	$ 1.82
Weighted average shares - basic	113,511,369	119,251,689
Weighted average shares - diluted	114,028,145	119,899,844